Comparison of long-term safety and efficacy of omalizumab in chronic urticaria: 9 year retrospective study

J. Marcelino, A. C. Costa, P. Silva, A. Mendes, E. Alonso, F. Duarte, P. Aguiar, E. Pedro, M. Pereira Barbosa

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)558-558
JournalAllergy: European Journal of Allergy and Clinical Immunology
Issue numberSuppl102
Publication statusPublished - Aug 2016
EventEuropean Academy of Allergy and Clinical Immunology Congress - Vienna, Austria
Duration: 11 Jun 201615 Jun 2016

Cite this